Last updated on November 2010

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

Brief description of study

The purpose of this study is to look at two doses of long-acting injectable risperidone (Risperdal Consta). The study will use a usual dose of Risperdal Consta (50 mg given every two weeks) or a higher dose (75 mg-100 mg given every two weeks) to see which one is better at improving symptoms of schizophrenia or schizoaffective disorder.

Detailed Study Description

This six month double-blind,randomized trial is designed to compare the efficacy of high dose long acting risperidone ( 75 mg-100 mg q2 weeks or its equivalent) with standard doses of long acting risperidone (≤50 mg/q 2weeks) for Total Psychopathology, positive, negative, and depressive symptoms, and cognition in patients who are considered to be poor responders by themselves, significant others, or clinicians. This will include two types of inadequately responding patients—those who are treatment resistant by research criteria (Kane et al., 1988) and those with inadequate response

Clinical Study Identifier: NCT00539071

Contact Investigators or Research Sites near you

Start Over

Herbert Meltzer, M.D.

Vanderbilt Psychiatric Hospital
Nashville, TN United States
  Connect »